The glucagon-like peptide-1 (GLP-1) receptor agonist is designed to enhance glycemic control in adults and children 10 years ...

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...